178 related articles for article (PubMed ID: 22301813)
21. Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.
Trancikova A; Mamais A; Webber PJ; Stafa K; Tsika E; Glauser L; West AB; Bandopadhyay R; Moore DJ
PLoS One; 2012; 7(10):e47784. PubMed ID: 23082216
[TBL] [Abstract][Full Text] [Related]
22. A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease Using RapidFire Mass Spectrometry.
Leveridge M; Collier L; Edge C; Hardwicke P; Leavens B; Ratcliffe S; Rees M; Stasi LP; Nadin A; Reith AD
J Biomol Screen; 2016 Feb; 21(2):145-55. PubMed ID: 26403521
[TBL] [Abstract][Full Text] [Related]
23. Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.
Greggio E
Biochem Soc Trans; 2012 Oct; 40(5):1058-62. PubMed ID: 22988865
[TBL] [Abstract][Full Text] [Related]
24. Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.
Vancraenenbroeck R; Lobbestael E; Weeks SD; Strelkov SV; Baekelandt V; Taymans JM; De Maeyer M
Biochim Biophys Acta; 2012 Mar; 1824(3):450-60. PubMed ID: 22251894
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology changes associated with LRRK2 mutations in Parkinson's disease.
Lu YW; Tan EK
J Neurosci Res; 2008 Jul; 86(9):1895-901. PubMed ID: 18338801
[TBL] [Abstract][Full Text] [Related]
26. Leucine-rich repeat kinase 2: relevance to Parkinson's disease.
Guo L; Wang W; Chen SG
Int J Biochem Cell Biol; 2006; 38(9):1469-75. PubMed ID: 16600664
[TBL] [Abstract][Full Text] [Related]
27. Measuring the activity of leucine-rich repeat kinase 2: a kinase involved in Parkinson's disease.
Lee BD; Li X; Dawson TM; Dawson VL
Methods Mol Biol; 2012; 795():45-54. PubMed ID: 21960214
[TBL] [Abstract][Full Text] [Related]
28. New biochemical approaches towards understanding the Parkinson's disease-associated kinase, LRRK2.
Liou GY; Gallo KA
Biochem J; 2009 Oct; 424(1):e1-3. PubMed ID: 19839940
[TBL] [Abstract][Full Text] [Related]
29. Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.
Gloeckner CJ; Boldt K; von Zweydorf F; Helm S; Wiesent L; Sarioglu H; Ueffing M
J Proteome Res; 2010 Apr; 9(4):1738-45. PubMed ID: 20108944
[TBL] [Abstract][Full Text] [Related]
30. The GTPase function of LRRK2.
Taymans JM
Biochem Soc Trans; 2012 Oct; 40(5):1063-9. PubMed ID: 22988866
[TBL] [Abstract][Full Text] [Related]
31. ROCO kinase activity is controlled by internal GTPase function.
Weiss B
Sci Signal; 2008 Jun; 1(23):pe27. PubMed ID: 18544747
[TBL] [Abstract][Full Text] [Related]
32. LRRK2 in Parkinson's disease: function in cells and neurodegeneration.
Webber PJ; West AB
FEBS J; 2009 Nov; 276(22):6436-44. PubMed ID: 19804415
[TBL] [Abstract][Full Text] [Related]
33. LRRK2 pathobiology in Parkinson's disease.
Martin I; Kim JW; Dawson VL; Dawson TM
J Neurochem; 2014 Dec; 131(5):554-65. PubMed ID: 25251388
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the WD40 domain dimer of LRRK2.
Zhang P; Fan Y; Ru H; Wang L; Magupalli VG; Taylor SS; Alessi DR; Wu H
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1579-1584. PubMed ID: 30635421
[TBL] [Abstract][Full Text] [Related]
35. Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.
Nguyen AP; Moore DJ
Adv Neurobiol; 2017; 14():71-88. PubMed ID: 28353279
[TBL] [Abstract][Full Text] [Related]
36. Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.
Gandhi PN; Chen SG; Wilson-Delfosse AL
J Neurosci Res; 2009 May; 87(6):1283-95. PubMed ID: 19025767
[TBL] [Abstract][Full Text] [Related]
37. GTPase activity plays a key role in the pathobiology of LRRK2.
Xiong Y; Coombes CE; Kilaru A; Li X; Gitler AD; Bowers WJ; Dawson VL; Dawson TM; Moore DJ
PLoS Genet; 2010 Apr; 6(4):e1000902. PubMed ID: 20386743
[TBL] [Abstract][Full Text] [Related]
38. Development of an enzyme-linked immunosorbent assay for detection of cellular and in vivo LRRK2 S935 phosphorylation.
Delbroek L; Van Kolen K; Steegmans L; da Cunha R; Mandemakers W; Daneels G; De Bock PJ; Zhang J; Gevaert K; De Strooper B; Alessi DR; Verstreken P; Moechars DW
J Pharm Biomed Anal; 2013 Mar; 76():49-58. PubMed ID: 23313773
[TBL] [Abstract][Full Text] [Related]
39. Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate.
Krumova P; Reyniers L; Meyer M; Lobbestael E; Stauffer D; Gerrits B; Muller L; Hoving S; Kaupmann K; Voshol J; Fabbro D; Bauer A; Rovelli G; Taymans JM; Bouwmeester T; Baekelandt V
FASEB J; 2015 Jul; 29(7):2980-92. PubMed ID: 25854701
[TBL] [Abstract][Full Text] [Related]
40. ARHGEF7 (Beta-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2.
Haebig K; Gloeckner CJ; Miralles MG; Gillardon F; Schulte C; Riess O; Ueffing M; Biskup S; Bonin M
PLoS One; 2010 Oct; 5(10):e13762. PubMed ID: 21048939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
